Medical Device Classification not Centrally Stored

Medical Device Classification not Centrally Stored

A recent discussion with the MHRA has provided enlightening:

At present no single organisation holds details of all medical devices – there are plans for the creation of a European Database, however these are not yet in place.

The medical device regulations differ from the medicines regulations in that no ‘licence’ is issued by any EU Competent Authority as is the case for medicinal products. A medical device may be CE marked in one Member State and then freely placed on the market in any other Member State. The requirements under the medical device directives are for the manufacturer to demonstrate the products conformity to the requirements and to CE mark the product. The Directives require that Class I medical devices and in vitro diagnostic medical devices are registered with the Competent Authority in which the manufacturer or his authorised representative is based, however all other classes of medical device are CE marked via a duly designated Notified Body, who again may be located in any EU Member State. The Notified Bodies are responsible for confirming that the devices meet the requirements of the regulations and once this has been done by issuing a CE certificate to the manufacturer for the devices concerned.

All manufacturers of medical devices will provide details of their products classification and CE marking conformity route to each EU Competent Authority for medical devices upon request,  however this information may only be requested when there is reason to believe that the product concerned is not in conformity with the requirements of the medical device directives. Manufacturers are not obliged to provide this information to other third parties, although some are happy to do so or provide details on their websites.

Damien Bové works as a drug development consultant (pharmaceutical or biotechnology) and regulatory consultant, we work with our clients to define a drug development target, define a drug development strategy, define a regulatory strategy or define a commercial strategy. Our clients are generally raising funds or looking to license out their technology and we help them achieve it. If you want to know more don’t hesitate to get in touch.

Avoid Expensive Mistakes, Keep On Top of New and Changing Regulations for Free.

As you know this website is a great resource for keeping up to date with developments and regulations, why not get our FREE monthly regulatory and market round up. You can un-subscribe at any time and we do not share your details with anybody.

First name

E-mail address

This guideline ap
recombinant vaccines for the prevention and treatment of infectious disease, and provides guidance on quality, non-clinical and clinical aspects.
ida consultants freestrategyconsultation 515x64 Medical Device Classification not Centrally Stored

ida 100programme 515x64 LowRes Medical Device Classification not Centrally Stored

Turn your Business Into an Investor Magnet

How to Write a Business Plan – Free E-Course

Get the secrets that turns your project into an investment magnet, 100% of our clients raise the finance they need to take their projects to the next stage, we will share these secrets with you. – Sign up for Free

“Please note that the pages on this website are designed to provide you with general information only. We make no warranties, representations or undertakings about any of its content. This includes the completeness, accuracy and fitness for any particular purpose, or the content of any third party site referred to or accessed through it. You are personally responsible for ensuring that the information is correct and we will not be held liable or accountable for any mistakes that occur.”


For Assistance with Regulatory Planning and Exicution of Clinical Trials Click Here


Damien Bové is THE Drug Development and Regulatory Consultant (pharmaceutical or biotechnology), I work with my clients to define a drug development target, define a drug development strategy, define a regulatory strategy or define a commercial strategy. Our clients are generally raising funds or looking to license out their technology and we help them achieve it. If you want to know more don’t hesitate to get in touch.


Avoid Expensive Mistakes, Keep On Top of New and Changing Regulations for Free!

Fill Out the Short Form Below…




Sign up for the most value add free newsource you can get for free. We spend a huge amount of time and effort monitoring the main drug / device regulators websites for changes in the regulatory environment, and capture between 20 and 40 new regulations, rules and initiatives each month, and summaries them in a fantastic FREE monthly Regulatory and Market Round Up. You can Un-Subscribe at any time and we don not share your details with anybody. You can’t afford to miss out on this service. Just fill in the form below.

“Please note that the pages on this website are designed to provide you with general information only. We make no warranties, representations or undertakings about any of its content. This includes the completeness, accuracy and fitness for any particular purpose, or the content of any third party site referred to or accessed through it. You are personally responsible for ensuring that the information is correct and we will not be held liable or accountable for any mistakes that occur.”

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>